{
    "organizations": [],
    "uuid": "94919ef5691da5ad37fb580da5c53f335c0fcca6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-neurovive-pharmaceutical-q4-pre-ta/brief-neurovive-pharmaceutical-q4-pre-tax-loss-widens-to-sek-14-8-mln-idUSFWN1QA014",
    "ord_in_thread": 0,
    "title": "BRIEF-Neurovive Pharmaceutical Q4 Pre-Tax Loss Widens To SEK 14.8 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Neurovive Pharmaceutical Ab:\n* Q4 NET REVENUE SEK ‍0​ VERSUS SEK 14,000 YEAR AGO * Q4 PRE-TAX LOSS SEK 14.8 MILLION VERSUS LOSS SEK 14.6 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-20T15:38:00.000+02:00",
    "crawled": "2018-02-21T21:13:02.017+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "neurovive",
        "pharmaceutical",
        "ab",
        "q4",
        "net",
        "revenue",
        "sek",
        "versus",
        "sek",
        "year",
        "ago",
        "q4",
        "loss",
        "sek",
        "million",
        "versus",
        "loss",
        "sek",
        "million",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}